Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann, Wen-Yi Huang, Kathryn Hughes Barry, Erikka Loftfield
{"title":"摘要:在前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验中,终生酒精摄入量增加与结直肠腺瘤和结直肠癌风险的关系","authors":"Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann, Wen-Yi Huang, Kathryn Hughes Barry, Erikka Loftfield","doi":"10.1158/1538-7445.am2025-1197","DOIUrl":null,"url":null,"abstract":"Introduction: Recent alcohol drinking has been associated with higher colorectal cancer (CRC) risk. However, research on lifetime alcohol drinking in relation to colorectal adenoma (CRC precursor) and CRC risk is limited. We aimed to estimate the association of average lifetime alcohol drinking and change in alcohol consumption over adulthood with incident colorectal adenoma and cancer. Methods: U.S. adults enrolled in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial were asked about alcohol intake during four age periods (18-24, 25-39, 40-54, and ≥55 years) as part of a dietary history questionnaire (DHQ). Participants were also asked about alcohol consumption in the year prior to the DHQ (reflecting current drinking). Average lifetime alcohol intake was calculated as average drinks per week from early adulthood (age 18-24) until age at DHQ completion (median of 65 years). Change in alcohol intake was defined as the difference between alcohol intake at the DHQ and age 18-24. Incident adenomas (n=807, including 196 advanced adenomas) were defined in the screening arm based on a negative baseline trial screen and a positive follow-up trial screen 3 or 5 years later; controls (n=11, 446) were defined based on negative baseline and follow-up screens. CRC incidence (n=1, 679) was defined based on 20 years of cancer follow-up in both trial arms. Multivariable-adjusted logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) for incident adenoma. Multivariable-adjusted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% CI for CRC. Models adjusted for a number of potential confounders including demographic factors, body mass index, family history of CRC, and various dietary factors. P-values for interaction between alcohol intake and sex were computed using likelihood ratio tests comparing models with and without the interaction terms. Results: Increasing alcohol intake by 1 drink/day every 10 years was associated with higher risk of adenoma (OR=1.19, CI: 1.02-1.39), advanced adenoma (OR=1.41, CI: 1.11-1.79), and CRC (HR=1.11, CI: 0.99-1.24). Among men, drinking ≥14 drinks/week, compared to <1 drink/week, throughout adulthood was positively associated with risk of advanced adenoma (OR=1.83, CI: 0.95-3.50) as well as rectal (HR=1.80, CI: 1.03-3.13) and distal colon (HR=1.54, CI: 0.98-2.42) but not proximal colon (HR=0.96, CI: 0.71-1.31) cancer. Associations tended to be less pronounced among women, but with limited case numbers, we found no evidence of significant effect modification by sex (p-interaction>0.05). Conclusions: Our study suggests that increasing alcohol intake over the lifetime and higher average lifetime alcohol drinking is associated with a higher risk of advanced colorectal adenoma and CRC. Citation Format: Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann, Wen-Yi Huang, Kathryn Hughes Barry, Erikka Loftfield. Association of increasing alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular s); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1): nr 1197.","PeriodicalId":9441,"journal":{"name":"Cancer research","volume":"17 1","pages":""},"PeriodicalIF":12.5000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract 1197: Association of increasing alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial\",\"authors\":\"Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann, Wen-Yi Huang, Kathryn Hughes Barry, Erikka Loftfield\",\"doi\":\"10.1158/1538-7445.am2025-1197\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Recent alcohol drinking has been associated with higher colorectal cancer (CRC) risk. However, research on lifetime alcohol drinking in relation to colorectal adenoma (CRC precursor) and CRC risk is limited. We aimed to estimate the association of average lifetime alcohol drinking and change in alcohol consumption over adulthood with incident colorectal adenoma and cancer. Methods: U.S. adults enrolled in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial were asked about alcohol intake during four age periods (18-24, 25-39, 40-54, and ≥55 years) as part of a dietary history questionnaire (DHQ). Participants were also asked about alcohol consumption in the year prior to the DHQ (reflecting current drinking). Average lifetime alcohol intake was calculated as average drinks per week from early adulthood (age 18-24) until age at DHQ completion (median of 65 years). Change in alcohol intake was defined as the difference between alcohol intake at the DHQ and age 18-24. Incident adenomas (n=807, including 196 advanced adenomas) were defined in the screening arm based on a negative baseline trial screen and a positive follow-up trial screen 3 or 5 years later; controls (n=11, 446) were defined based on negative baseline and follow-up screens. CRC incidence (n=1, 679) was defined based on 20 years of cancer follow-up in both trial arms. Multivariable-adjusted logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) for incident adenoma. Multivariable-adjusted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% CI for CRC. Models adjusted for a number of potential confounders including demographic factors, body mass index, family history of CRC, and various dietary factors. P-values for interaction between alcohol intake and sex were computed using likelihood ratio tests comparing models with and without the interaction terms. Results: Increasing alcohol intake by 1 drink/day every 10 years was associated with higher risk of adenoma (OR=1.19, CI: 1.02-1.39), advanced adenoma (OR=1.41, CI: 1.11-1.79), and CRC (HR=1.11, CI: 0.99-1.24). Among men, drinking ≥14 drinks/week, compared to <1 drink/week, throughout adulthood was positively associated with risk of advanced adenoma (OR=1.83, CI: 0.95-3.50) as well as rectal (HR=1.80, CI: 1.03-3.13) and distal colon (HR=1.54, CI: 0.98-2.42) but not proximal colon (HR=0.96, CI: 0.71-1.31) cancer. Associations tended to be less pronounced among women, but with limited case numbers, we found no evidence of significant effect modification by sex (p-interaction>0.05). Conclusions: Our study suggests that increasing alcohol intake over the lifetime and higher average lifetime alcohol drinking is associated with a higher risk of advanced colorectal adenoma and CRC. Citation Format: Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann, Wen-Yi Huang, Kathryn Hughes Barry, Erikka Loftfield. Association of increasing alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular s); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1): nr 1197.\",\"PeriodicalId\":9441,\"journal\":{\"name\":\"Cancer research\",\"volume\":\"17 1\",\"pages\":\"\"},\"PeriodicalIF\":12.5000,\"publicationDate\":\"2025-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.am2025-1197\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1538-7445.am2025-1197","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
近期饮酒与结直肠癌(CRC)风险增高有关。然而,终生饮酒与结直肠腺瘤(CRC前体)和CRC风险的关系研究有限。我们的目的是估计平均一生饮酒量和成年期饮酒量变化与结直肠腺瘤和癌症的关系。方法:参加前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验的美国成年人被问及在四个年龄段(18-24岁、25-39岁、40-54岁和≥55岁)的酒精摄入量,作为饮食史问卷(DHQ)的一部分。参与者还被问及在DHQ前一年的饮酒情况(反映当前饮酒情况)。平均终生酒精摄入量计算为从成年早期(18-24岁)到DHQ完成年龄(中位数为65岁)每周平均饮酒量。酒精摄入量的变化定义为DHQ和18-24岁时酒精摄入量的差异。偶发性腺瘤(n=807,包括196例晚期性腺瘤)在筛查组中根据阴性基线试验筛查和3或5年后的阳性随访试验筛查确定;对照(n= 11,446)根据阴性基线和随访筛查定义。CRC发病率(n= 1679)是根据两个试验组20年的癌症随访来确定的。使用多变量校正logistic回归模型来估计偶发腺瘤的比值比(OR)和95%置信区间(CI)。多变量校正Cox比例风险回归模型用于估计CRC的风险比(HR)和95% CI。模型调整了许多潜在的混杂因素,包括人口因素、体重指数、结直肠癌家族史和各种饮食因素。使用似然比检验比较有和没有相互作用项的模型,计算酒精摄入量和性别之间相互作用的p值。结果:每10年增加1杯/天的酒精摄入量与腺瘤(OR=1.19, CI: 1.02-1.39)、晚期腺瘤(OR=1.41, CI: 1.11-1.79)和结直肠癌(HR=1.11, CI: 0.99-1.24)的高风险相关。在男性中,整个成年期饮酒量≥14杯/周与饮酒量≥1杯/周相比,与晚期腺瘤(OR=1.83, CI: 0.95-3.50)、直肠(HR=1.80, CI: 1.03-3.13)和远端结肠(HR=1.54, CI: 0.98-2.42)的风险呈正相关,但与近端结肠(HR=0.96, CI: 0.71-1.31)的风险无关。相关性在女性中往往不太明显,但由于病例数有限,我们没有发现性别显著影响改变的证据(p-interaction>0.05)。结论:我们的研究表明,一生中酒精摄入量的增加和平均终生饮酒量的增加与晚期结直肠癌和结直肠癌的高风险相关。引文格式:Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann,黄文怡,Kathryn Hughes Barry, Erikka Loftfield。在前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验中,终生增加酒精摄入量与结直肠腺瘤和结直肠癌风险的关系摘自:《2025年美国癌症研究协会年会论文集》;第1部分(常规);2025年4月25日至30日;费城(PA): AACR;中国生物医学工程学报,2009;31(5):391 - 391。
Abstract 1197: Association of increasing alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Introduction: Recent alcohol drinking has been associated with higher colorectal cancer (CRC) risk. However, research on lifetime alcohol drinking in relation to colorectal adenoma (CRC precursor) and CRC risk is limited. We aimed to estimate the association of average lifetime alcohol drinking and change in alcohol consumption over adulthood with incident colorectal adenoma and cancer. Methods: U.S. adults enrolled in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial were asked about alcohol intake during four age periods (18-24, 25-39, 40-54, and ≥55 years) as part of a dietary history questionnaire (DHQ). Participants were also asked about alcohol consumption in the year prior to the DHQ (reflecting current drinking). Average lifetime alcohol intake was calculated as average drinks per week from early adulthood (age 18-24) until age at DHQ completion (median of 65 years). Change in alcohol intake was defined as the difference between alcohol intake at the DHQ and age 18-24. Incident adenomas (n=807, including 196 advanced adenomas) were defined in the screening arm based on a negative baseline trial screen and a positive follow-up trial screen 3 or 5 years later; controls (n=11, 446) were defined based on negative baseline and follow-up screens. CRC incidence (n=1, 679) was defined based on 20 years of cancer follow-up in both trial arms. Multivariable-adjusted logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) for incident adenoma. Multivariable-adjusted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% CI for CRC. Models adjusted for a number of potential confounders including demographic factors, body mass index, family history of CRC, and various dietary factors. P-values for interaction between alcohol intake and sex were computed using likelihood ratio tests comparing models with and without the interaction terms. Results: Increasing alcohol intake by 1 drink/day every 10 years was associated with higher risk of adenoma (OR=1.19, CI: 1.02-1.39), advanced adenoma (OR=1.41, CI: 1.11-1.79), and CRC (HR=1.11, CI: 0.99-1.24). Among men, drinking ≥14 drinks/week, compared to <1 drink/week, throughout adulthood was positively associated with risk of advanced adenoma (OR=1.83, CI: 0.95-3.50) as well as rectal (HR=1.80, CI: 1.03-3.13) and distal colon (HR=1.54, CI: 0.98-2.42) but not proximal colon (HR=0.96, CI: 0.71-1.31) cancer. Associations tended to be less pronounced among women, but with limited case numbers, we found no evidence of significant effect modification by sex (p-interaction>0.05). Conclusions: Our study suggests that increasing alcohol intake over the lifetime and higher average lifetime alcohol drinking is associated with a higher risk of advanced colorectal adenoma and CRC. Citation Format: Caitlin P. O'Connell, Sonja I. Berndt, Kenechukwu Chudy-Onwugaje, Andrew T. Kunzmann, Wen-Yi Huang, Kathryn Hughes Barry, Erikka Loftfield. Association of increasing alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular s); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1): nr 1197.
期刊介绍:
Cancer Research, published by the American Association for Cancer Research (AACR), is a journal that focuses on impactful original studies, reviews, and opinion pieces relevant to the broad cancer research community. Manuscripts that present conceptual or technological advances leading to insights into cancer biology are particularly sought after. The journal also places emphasis on convergence science, which involves bridging multiple distinct areas of cancer research.
With primary subsections including Cancer Biology, Cancer Immunology, Cancer Metabolism and Molecular Mechanisms, Translational Cancer Biology, Cancer Landscapes, and Convergence Science, Cancer Research has a comprehensive scope. It is published twice a month and has one volume per year, with a print ISSN of 0008-5472 and an online ISSN of 1538-7445.
Cancer Research is abstracted and/or indexed in various databases and platforms, including BIOSIS Previews (R) Database, MEDLINE, Current Contents/Life Sciences, Current Contents/Clinical Medicine, Science Citation Index, Scopus, and Web of Science.